FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Cardinal Health Monoject Inspection Violations

FDA warns Cardinal Health it is distributing unapproved medical devices that also have a Quality System Regulation violation.

latest-news-card-1
Medical Devices

FDA Tightening Research Use Only Tests: Lawyers

Three SheppardMullin attorneys say that manufacturers of tests labeled for research use only should review customer lists and promotional claims to be...

latest-news-card-1
Human Drugs

Cancer Trial Eligibility Criteria Guidance

FDA publishes a draft guidance to help sponsors expand eligibility for cancer drug clinical trials in terms of washout periods and concomitant medicat...

latest-news-card-1
Medical Devices

InfuTronix Recalls Malfunctioning Infusion Pumps

InfuTronix recalls its Nimbus infusion pump systems due to multiple potential failure modes that may include battery failure, upstream blockage (occlu...

latest-news-card-1
Human Drugs

Cancer Trial Performance Status Eligibility Criteria

FDA publishes a draft guidance on using patient performance status as eligibility criteria for cancer drug trials.

latest-news-card-1
Human Drugs

Fresenius Recalls Stay-Safe Catheter Sets

Fresenius Medical Care recalls its Stay-Safe Catheter Extension Sets and Stay-Safe/Luer Lock Adapters to correct their instructions for use to prevent...

latest-news-card-1
Human Drugs

Laboratory Values Cancer Trial Eligibility Criteria

FDA publishes a draft guidance with recommendations for increasing cancer drug trial participant diversity by selecting appropriate laboratory values ...

latest-news-card-1
Federal Register

Electronic Signatures Info Collection Approved

Federal Register notice: FDA announces that OMB has approved an information collection entitled Electronic Records: Electronic Signatures.

latest-news-card-1
Federal Register

Promo Labeling Guide for Biologic Products

Federal Register notice: FDA makes available a revised draft guidance entitled Promotional Labeling and Advertising Considerations for Prescription Bi...

latest-news-card-1
Human Drugs

FDA Fast Track for Compass Biliary Tract Cancer Drug

FDA grants fast track designation to Compass CTX-009 that is in a Phase 2 study with paclitaxel to treat some biliary tract tumors.